BCM
LABU icon

Brasada Capital Management’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Brasada Capital Management’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50
Closed -$78K – 283
2017
Q4 		$78K Buy
+50
New +$76.5K 0.03% 168

Other funds holding LABU

HJMC
Hellman Jordan Management Company Quincy, Massachusetts $58.9M AUM 18.56% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $10.4B AUM 4.78% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
EWA
Exencial Wealth Advisors Oklahoma City, Oklahoma $3.22B AUM 20.17% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Brasada Capital Management's LABU Position: Q1 2018 in Review

Brasada Capital Management sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2018, closing a stake of 50 shares — an estimated $78K sold.

Brasada Capital Management first reported a position in LABU in Q4 2017 and held it in 1 quarter. The position peaked at $78K in Q4 2017. 13 funds tracked by Wall St. Rank hold LABU as of Q1 2018.

  • Brasada Capital Management reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2018 after selling out during the quarter.
  • Brasada Capital Management sold 50 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2018, an estimated $78K.
  • Brasada Capital Management first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q4 2017 and held it in 1 quarter.
  • Brasada Capital Management's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $78K in Q4 2017.
  • 13 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2018.

Based on Brasada Capital Management's 13F filing for Q1 2018, filed 15 May 2018.